Renal Cancer - Results from #5860

A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review February 8, 2016

Pazopanib in the treatment of advanced renal cell carcinoma February 8, 2016

A Randomized Phase 2/3 Study of Naptumomab Estafenatox + IFN-α vs IFN-α in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis. February 7, 2016

Sunitinib activates Axl signaling in renal cell cancer February 5, 2016

SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer February 5, 2016

Baseline tumor volume in assessing prognosis of patients with intermediate-risk synchronous metastatic renal cell carcinoma February 3, 2016

Combined Angiogenesis and Proliferation Markers' Expressions as Long-Term Prognostic Factors in Renal Cell Cancer February 3, 2016

Renal cell carcinoma with vena caval involvement: a contemporary clinicopathologic analysis of 53 cases February 1, 2016

Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment February 1, 2016

PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses February 1, 2016

Current status of immunotherapy February 1, 2016

Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma January 29, 2016

Pulmonary metastasectomy from renal cell carcinoma including 3 cases with sarcomatoid component January 29, 2016

Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms January 28, 2016

High TXNDC5 expression predicts poor prognosis in renal cell carcinoma January 28, 2016

Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients January 27, 2016

Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance January 26, 2016

Radiation therapy following targeted therapy in oligometastatic renal cell carcinoma January 26, 2016

Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence. January 19, 2016

Retrospective analysis of survival after resection of pancreatic renal cell carcinoma metastases January 19, 2016

Page 294 of 456